February 18, 2016 — Navidea Biopharmaceuticals Inc. last week announced that the first patient has been enrolled in a ...
February 18, 2016 — Manhattan Scientifics Inc. announced its wholly-owned subsidiary Senior Scientific LLC, which is ...
February 3, 2016 — The nuclear medicine, proton therapy and brachytherapy markets represent less than 0.1 percent of ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
January 29, 2016 — A biochemical compound developed as a radioactive tracer for cell proliferation shows increasing ...
January 26, 2016 — University of Missouri researcher Silvia Jurisson and her interdisciplinary team recently received a ...
January 21, 2016 — Researchers at Thomas Jefferson University have found the method they developed to image the prostate ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and ...
December 11, 2015 — Navidea Biopharmaceuticals Inc. announced that results from an investigator-initiated imaging study ...
November 3, 2015 — Australian immuno-oncology company Minomic International Ltd has struck an agreement to launch the ...
October 19, 2015 — Siemens’ PETNET Solutions Inc., a wholly owned subsidiary of Siemens Healthcare, will formulate the ...
October 2, 2015 — Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S ...
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...
September 18, 2015 — A recently developed drug was significantly better at detecting recurring prostate cancer in early ...
September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation ...
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...
September 14, 2015 — ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's ...
September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and ...
September 11, 2015 — Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of ...
September 3, 2015 — Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business ...
August 31, 2015 — NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 ...